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Background: Little is known about the time course of changes in the microarchitecture of the 
tibial epiphysis with rheumatoid arthritis (RA), although such information would be valuable 
in predicting risk of fracture. Therefore, we used in vivo microcomputed tomography (µ-CT) 
to assess patterns of microarchitectural alterations in the tibial epiphysis using collagen-induced 
RA in an animal model.
Methods: Bovine type II collagen was injected intradermally into the tails of rats for 
induction of RA. The tibial joints were scanned by in vivo µ-CT at 0, 4, and 8 weeks following 
injection. Microarchitectural parameters were measured to evaluate alteration patterns of bone 
microarchitecture at the tibial epiphysis.
Results: The microarchitectural alterations in an RA group were significantly different from 
those in a control group from 0 to 4 weeks and from 4 to 8 weeks following injection (P , 0.05). 
The distribution of trabecular bone thickness and trabecular bone separation from 0 weeks to 
8 weeks differed significantly (P , 0.05).
Conclusion: These results indicate that the patterns of microarchitectural alterations at the 
tibial epiphysis are strongly affected by collagen-induced progression of RA and entail a severe 
risk of fracture at the tibial epiphysis. This study represents a valuable first approach to tracking 
periodic and continuous changes in the microarchitectural characteristics of the tibial epiphysis 
with collagen-induced RA.
Keywords: collagen-induced rheumatoid arthritis, in vivo microcomputed tomography, periodic 
microarchitecture alteration pattern, trabecular bone thickness, trabecular bone separation
Introduction
Rheumatoid arthritis (RA) is a chronic systemic inflammatory autoimmune disease 
and secondarily a disorder of the joints. Exacerbation of the arthritis may lead to joint 
damage and increased risk of fractures.1 The prevalence of RA in the adult population 
is about 1%, which is lower than the prevalence of osteoarthritis. However, RA is 
observed mainly in adults aged 25–55 years. RA symptoms have also been reported 
in 20-month-old infants and in 10% of persons aged more than 65 years.2,3 Thus, 
a person of any age can be affected by RA, in contrast with osteoarthritis.4 In the US, 
approximately four million people suffer from RA, and seven trillion US dollars are 
spent annually to manage the disabilities and loss of function related to RA.4 As a result, 
there is considerable interest in RA research and the needs of patients with RA.
Many researchers have studied RA in animal models. Collagen-induced arthritis 
(CIA) is widely used in many studies of RA to induce an experimental model of RA, 
because the pathogenesis of CIA is, in many ways, similar to that of human RA.6,8 
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However, most of the studies reported to date have ana-
lyzed only RA-induced bone mass or bone mineral density 
alterations,5,12,14–16 and there is a lack of information about 
the pattern of alterations in the bone microarchitecture. Some 
reports have indicated that rheumatic symptoms contribute 
significantly to increased bone fragility and risk of stress 
fracture,20–23 and predictions of bone fracture risk could be 
greatly improved by analyzing the bone microarchitecture.18,19 
Therefore, detailed characterization of changes in bone 
microarchitecture is needed to improve the prediction of bone 
fracture risk associated with RA. Recently, Wang et al13 and 
Jimenez-Boj et al17 analyzed microarchitectural alterations 
related to RA at the tibial epiphysis. However, their studies 
had the limitation that the periodic and continuous patterns of 
microarchitectural alterations were not tracked individually. 
Thus, individual differences in microarchitectural character-
istics at the time of onset and changes thereof during disease 
progression were not considered, and there were no periodic 
observations of continuous changes.13,17
In the current study, we quantified periodic and con-
tinuous collagen-induced RA-related alterations in the 
microarchitecture of the tibial epiphysis using in vivo 
microcomputed tomography (µ-CT), with the overall aim 
of improving the accuracy of bone fracture risk prediction 
in patients with RA.
Materials and methods
Animal model
The animal experiments in this study complied with the 
Animal Protection and Usage guidelines and regulations of 
Yonsei University (YWC-091113-1). Fourteen 8-week-old, 
white, male Sprague Dawley rats (average weight 250 ± 7 g) 
were used. The rats were housed at Yonsei University 
Laboratory Animal Research Center for 2 weeks to allow 
them to acclimatize (temperature 23°C ± 3°C, humidity 
50% ± 10%). A 12-hour day/12-hour night cycle was used. 
The rats were assigned to a group in which experimental RA 
was induced (RA1, RA2, RA3, RA4, RA5, RA6, RA7) or a 
control group (C1, C2, C3, C4, C5, C6, C7). To induce RA 
in the rats, an emulsified solution of 300 µg bovine type II 
collagen (CII, Sigma-Aldrich, St Louis, MO) and an equal 
amount of incomplete Freund’s adjuvant (Sigma-Aldrich) 
were injected intradermally. In total, 0.1 mL of emulsion 
was injected at multiple locations at the base of the tail with 
a 26-gauge needle. Seven days after primary immunization, 
the same volume of emulsion was injected as a booster 
containing 100 µg of CII in incomplete Freund’s adjuvant. 
For the control group, the same amount of saline was injected 
at multiple locations at the base of the tail with a 26-gauge 
needle.6,7,9,26
In vivo microcomputed tomography
Images of the knee joints of the rats in the control and RA 
groups were periodically and continuously obtained using the 
SkyScan 1076 device for in vivo µ-CT (SkyScan, Kontich, 
Belgium) to analyze the microarchitectural characteristics 
at the tibial epiphysis. Each knee joint was scanned at an 
isotrophic voxel resolution of 35 × 35 × 35 µm at the begin-
ning of the experiment (ie, before primary immunization) 
and at 4 and 8 weeks after primary immunization to assess 
the patterns of microarchitectural changes. The scanning 
parameters were as follows: tube voltage, 100 kV; tube cur-
rent, 100 µA; filter, 1.0 mm; and gantry rotation angle, 0.7°. 
Flat-field correction and beam-hardening factor correction 
were carried out to rectify the beam-hardening effect.10 
In addition, the rats were anesthetized with ketamine hydro-
chloride (1 mL/kg, Huons, Korea) and xylazine hydrochloride 
(0.33 mL/kg, Bayer, Seoul, Korea) to obtain the desired µ-CT 
images. Physical monitoring systems were also used to 
observe stress levels in the animals during the scans, and a 
shutter was used to prevent exposure of the rats to radiation 
(Figure 1).11
Microarchitectural characteristics
The microarchitectural parameters were calculated using CTAn 
version 1.8.1.2 software (SkyScan, Kontich, Belgium). After 
reconstruction of the two-dimensional images from µ-CT, 
trabecular bone from the epiphysis 600 µm above the growth 
plate was chosen as the volume of interest (Figure 1). The 
microarchitectural parameters studied in the control and RA 
groups were: bone volume to tissue volume ratio (BV/TV, %); 
bone surface to bone volume ratio (BS/BV, mm−1); trabecular 
bone pattern factor (Tb.Pf, mm−1); trabecular bone num-
ber (Tb.N, mm−1); trabecular bone thickness (Tb.Th, mm); 
and trabecular bone separation (Tb.Sp, mm). BV/TV indicates 
the percentage of bone volume in the total tissue volume and 
is an indicator of changes in total bone volume. BS/BV is 
the ratio of the selected bone surface to the bone volume and 
reflects bone turnover. The trabecular bone pattern factor is an 
indicator of the connectivity in trabecular bone; the higher this 
value, the lower the connectivity and vice versa. The trabecular 
bone number is the amount of trabecular bone per unit length, 
and trabecular bone thickness is an index of trabecular bone 
thickness; the higher the value of the trabecular bone number 
or trabecular bone thickness, the higher the level of bone 
formation. Trabecular bone separation indicates the average 
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distance between trabecular bone structures, which means that 
the narrower the gap, the higher the bone density. In addition, 
analyses of the distribution of trabecular bone thickness and 
separation were performed to identify in detail the progressive 
heterogeneity of the trabecular bone microarchitecture in RA 
over time through collagen-induced RA.
Validation of collagen-induced RA
To assess the onset and progression of RA using radiologic 
methods, surface deformity and damage above the epiphysis 
was traced and observed in reconstructed three-dimensional 
images of the knee joints. Mimics version 13.0 software 
(Materialise, Leuven, Belgium) was used to analyze external 
changes in the knee joints. Histologic examinations were also 
performed to validate the clinical induction of RA in the rats. 
For this purpose, the rats were sacrificed by CO
2
 inhalation 
immediately after µ-CT was performed at 8 weeks. The 
tissues were fixed in 10% paraformaldehyde for 8 hours at 
room temperature, and the remaining fixative was removed 
by handwashing after decalcification using a 15% ethylene-
diamine tetra-acetic acid solution. After dehydration, paraffin 
blocks of the tissues were produced by impregnation and 
embedding. Hematoxylin and eosin staining was performed 
on knee joint sections (4 µm in thickness).
Statistical analysis
All results are expressed as the mean ± standard devia-
tion. Two-way analysis of variance together with Tukey’s 
post hoc analysis were carried out to determine the sig-
nificance of periodic changes and differences between the 
groups (at 0, 4, and 8 weeks). The criterion for statistical 
significance was a P value , 0.05, and the analyses were 
performed using SPSS software version 17.0 (SPSS Inc, 
Chicago, IL).
Results
Changes in microarchitectural 
characteristics
Figure 2 shows the changes in microarchitectural char-
acteristics over time for the control and RA groups and 
a comparison of the two groups at weekly intervals. In 
terms of the periodic changes, comparing 4 weeks with 0 
weeks, BV/TV in the control group increased significantly 
(increase of 14.13% ± 4.40%; P , 0.05), while that in 
the RA group showed no significant change (decrease of 
3.25% ± 6.46%; P . 0.05). BS/BV in the control group 
decreased significantly (decrease of 3.39 ± 1.40 mm−1; 
P , 0.05), while BS/BV in the RA group increased 
significantly (increase of 2.42 ± 2.08 mm−1; P , 0.05). 
The trabecular bone pattern factor in the control group 
decreased significantly (decrease of 2.48 ± 1.21 mm−1; 
P , 0.05), but showed no signif icant change in the 
RA group (increase of 1.11 ± 1.59 mm−1; P . 0.05). 
Trabecular bone thickness in the control group increased 
significantly (increase of 0.09 ± 0.05 mm; P , 0.05), 
but decreased significantly in the RA group (decrease 
Micro-CT scan Monitoring Image reconstruction
Image align ROI and VOI acquisition Bone microarchitecture analysis
Figure 1 Assessments of alterations in trabecular bone microarchitecture using microcomputer tomography scanning, monitoring, image reconstruction, image alignment, 
ROI and VOI acquisition, and three-dimensional analyses.
Abbreviations: BV/TV, bone volume to tissue volume ratio; BS/BV, bone surface to bone volume ratio; Tb.Pf, trabecular bone pattern factor; Tb.N, trabecular bone number; 
Tb.Th, trabecular bone thickness; Tb.Sp, trabecular bone separation; ROI, region of interest; VOI, volume of interest.
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of 0.04 ± 0.02 mm; P , 0.05). Comparing 8 weeks with 
4 weeks, BV/TV showed no significant change in the control 
group (increase of 0.75% ± 4.12%; P . 0.05), but decreased 
markedly in the RA group (decrease of 21.78% ± 6.95%; 
P , 0.05). BS/BV in the control group showed no signifi-
cant change (increase of 0.006 ± 1.11 mm−1; P . 0.05), 
but increased significantly in the RA group (increase of 
6.01 ± 2.60 mm−1; P , 0.05). Trabecular bone pattern factor 
in the control group showed no significant change (increase 
of 0.15 ± 0.56 mm−1; P . 0.05), but increased significantly 
in the RA group (increase of 8.45 ± 1.91 mm−1; P , 0.05). 
The trabecular bone number value showed no significant 
change in the control group (increase of 0.02 ± 0.14 mm−1; 
P . 0.05), but decreased significantly in the RA group 
(decrease of 0.73 ± 0.20 mm−1; P , 0.05). Trabecular bone 
thickness showed no significant change in the control group 
(increase of 0.001 ± 0.05 mm; P . 0.05), but decreased 
significantly in the RA group (decrease of 0.03 ± 0.03 mm; 
P , 0.05). Trabecular bone separation increased sig-
nificantly in the RA group (increase of 0.09 ± 0.03 mm; 
P , 0.05), but showed no significant change in the control 
group (increase of 0.001 ± 0.02 mm; P . 0.05, Figure 2).
Regarding differences between the groups for each week, 
there was no significant difference at 0 weeks (P . 0.05). 
However, at 4 weeks, there was a significant difference 
in BV/TV (difference 22.31% ± 4.46%; control group, 
70.08% ± 5.28%; RA group, 47.77% ± 6.08%), BS/BV (dif-
ference 7.39 ± 1.62 mm-¹; control group, 8.07 ± 1.22 mm−1; 
RA group, 15.46 ± 1.95 mm−1), trabecular bone pat-
tern factor (difference 3.90 ± 1.77 mm−1; control group, 
−7.87% ± 0.43%; RA group, −3.97% ± 1.64%), trabecular 
bone number (difference 0.20 ± 0.18 mm−1; control group, 
1.76% ± 0.10%; RA group, 1.97% ± 0.11%), trabecular 
bone thickness (difference 0.16 ± 0.04 mm; control group, 
0.40 ± 0.05 mm; RA group, 0.24 ± 0.02 mm), and trabecular 
bone separation (difference 0.02 ± 0.02 mm; control group, 
0.24 ± 0.02 mm; RA group, 0.27 ± 0.01 mm) between the 
two groups (P , 0.05). At 8 weeks, there was a significant 
difference in BV/TV (difference 44.83% ± 7.10%; control 
group, 70.83% ± 4.40%; RA group, 25.99% ± 5.27%), 
0.0
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Trabecular bone pattern factor [1/mm] Trabecular bone number [1/mm]


























































Figure 2 Relative alterations in bone microarchitectural characteristics at the tibial epiphysis after 0, 4, and 8 weeks.
Notes: Solid line, control group; dotted line, RA group. *Differences between groups; **difference between weeks; P , 0.05.
Abbreviation: RA, rheumatoid arthritis.





Clinical Interventions in Aging 2012:7
Table 1 Incidence of changes in each microarchitectural parameter in terms of the individual analysis for control and RA groups
Control (n = 7) Rheumatoid arthritis (n = 7)
Increase in total  
number, n (%)
Decrease in total  
number, n (%)
Increase in total  
number, n (%)
Decrease in total 
number, n (%)
0 to 4 weeks
BV/TV 7 (100%) 0 (0%) 2 (29%) 5 (71%)
BS/BV 0 (0%) 7 (100%) 7 (100%) 0 (0%)
Tb.Pf 0 (0%) 7 (100%) 5 (71%) 2 (29%)
Tb.N 3 (43%) 4 (57%) 7 (100%) 0 (0%)
Tb.Th 7 (100%) 0 (0%) 0 (0%) 7 (100%)
Tb.Sp 0 (0%) 7 (100%) 7 (100%) 0 (0%)
4 to 8 weeks
BV/TV 3 (43%) 4 (57%) 0 (0%) 7 (100%)
BS/BV 4 (57%) 3 (43%) 7 (100%) 0 (0%)
Tb.Pf 3 (43%) 4 (57%) 7 (100%) 0 (0%)
Tb.N 2 (29%) 5 (71%) 0 (0%) 7 (100%)
Tb.Th 3 (43%) 4 (57%) 0 (0%) 7 (100%)
Tb.Sp 0 (0%) 7 (100%) 7 (100%) 0 (0%)
Abbreviations: BV/TV, bone volume/total volume; BS/BV, bone surface to bone volume; Tb.Pf, trabecular bone pattern factor; Tb.N, trabecular number; Tb.Th, trabecular 
thickness; Tb.Sp, trabecular separation.
BS/BV (difference 13.40 ± 2.30 mm−1; control group, 
8.18 ± 1.16 mm−1; RA group, 21.48 ± 1.97 mm−1), trabecular 
bone pattern factor (difference 12.20 ± 2.62 mm−1; control 
group, −7.72 ± 0.86 mm−1; RA group, 4.48 ± 2.22 mm−1), 
trabecular bone number (difference 0.54 ± 0.28 mm−1; con-
trol group, 1.78 ± 0.14 mm−1; RA group, 1.24 ± 0.22 mm−1), 
trabecular bone thickness (difference 0.19 ± 0.05 mm; control 
group, 0.40 ± 0.05 mm; RA group, 0.21 ± 0.02 mm) and tra-
becular bone separation (difference 0.11 ± 0.04 mm; control 
group, 0.25 ± 0.02 mm; RA group, 0.36% ± 0.04%) between 
the two groups (P , 0.05, Figure 2).
Table 1 summarizes the incidence of changes in each 
microarchitectural parameter in terms of individual analysis 
for the control and RA groups. A negative incidence was 
generally shown in the RA group relative to the control 
group. Comparing 4 weeks with 0 weeks, an increase in 
BV/TV, trabecular bone thickness, and trabecular bone 
separation, as well as a decrease in trabecular bone pattern 
factor, were shown for all animals (C1, C2, C3, C4, C5, 
C6, C7; 100%), in the control group. In contrast, BS/BV 
and trabecular bone number showed opposite patterns in 
all animals in the RA group (RA1, RA2, RA3, RA4, RA5, 
RA6, RA7; 100%) compared with those in the control 
group. Comparing 8 weeks with 4 weeks, an increase in 
BS/BV, trabecular bone pattern factor, and trabecular bone 
separation, as well as a decrease in BV/TV, trabecular bone 
number, and trabecular bone thickness were shown in all 
animals from the RA group (RA1, RA2, RA3, RA4, RA5, 
RA6, RA7; 100%). Trabecular bone separation showed 
a reverse pattern in all animals from the control group 
(C1, C2, C3, C4, C5, C6, C7; 100%) compared with that 
in the RA group.
Changes in microarchitectural 
characteristics
Periodic changes in the distributions of trabecular bone thick-
ness and trabecular bone separation in the control and RA 
groups and comparisons of these distributions for each week 
are shown for the two groups in Figures 3 and 4.
In terms of periodic changes in the distribution of trabecular 
bone thickness, comparing 4 weeks with 0 weeks, the percent-
age with trabecular bone thickness , 0.17 mm decreased 
significantly in the control group (decrease of 7.25% ± 2.96%; 
P , 0.05). The percentage with trabecular bone thickness in 
the range of 0.17–0.31 mm decreased significantly (decrease 
of 15.04% ± 9.27%; P , 0.05), and the percentage with 
trabecular bone thickness . 0.31 mm increased significantly 
(increase of 22.28% ± 10.71%; P , 0.05). In the RA group, 
there was no significant change in the percentage with trabe-
cular bone thickness , 0.17 mm (increase of 4.99% ± 6.25%; 
P . 0.05). The percentage with trabecular bone thickness in 
the range of 0.17–0.31 mm increased significantly (increase 
of 6.29% ± 1.69%; P , 0.05), and the percentage with 
trabecular bone thickness . 0.31 mm decreased significantly 
(decrease of 11.29% ± 5.95%; P , 0.05). Comparing 8 weeks 
with 4 weeks, there were no significant changes in the dis-
tribution of trabecular bone thickness in the control group 
(,0.17 mm; increase of 0.01% ± 1.41%, 0.17–0.31 mm; 
increase of 1.12% ± 10.27%, .0.31 mm; decrease of 
1.13% ± 11.64%; P . 0.05). In contrast, the percentage with 
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Figure 3 Trabecular bone thickness distribution at the tibial epiphysis after (A) 0 weeks, (B) 4 weeks, and (C) 8 weeks.
Notes: Vertical axis, bone percentage, %; horizontal axis, trabecular bone thickness, mm; %; black bar, control group; white bar, RA group. *Differences between groups; 
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Figure 4 Alterations in trabecular bone separation distribution at the tibial epiphysis after (A) 0 weeks, (B) 4 weeks, and (C) 8 weeks.
Notes: Vertical axis, bone percentage, %; horizontal axis, trabecular bone separation, mm; %; black bar, control group; white bar, RA group. *Differences between groups; 
**0–4, difference from 0 to 4 weeks; ***4–8, difference from 4 to 8 weeks.
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trabecular bone thickness , 0.17 mm increased significantly 
in the RA group (increase of 19.55% ± 9.26%; P , 0.05). 
The percentage with trabecular bone thickness in the range 
of 0.17–0.31 mm decreased (decrease of 13.91% ± 4.42%; 
P , 0.05), and there were no significant changes in the percent-
ages with trabecular bone thickness . 0.31 mm (decrease of 
5.65% ± 8.36%; P . 0.05). Regarding comparison of the two 
groups for each week (Figure 3), at 4 weeks, the percentage 
with trabecular bone thickness , 0.17 mm was significantly 
lower (16.24% ± 5.09%; P , 0.05) in the control group 
(3.97% ± 1.57%) than in the RA group (20.22% ± 5.57%). The 
percentage with trabecular bone thickness in the range of 0.17–
0.31 mm was significantly lower (28.55% ± 10.34%; P , 0.05) 
in the control group (33.84% ± 9.95%) than in the RA group 
(62.38% ± 2.87%), and the percentage with trabecular bone 
thickness . 0.31 mm was significantly higher (44.79% ± 9.77%; 
P , 0.05) in the control group (62.19% ± 11.49%) than in 
the RA group (17.40% ± 5.90%). At 8 weeks, the percentage 
with trabecular bone thickness , 0.17 mm was significantly 
lower (35.78% ± 6.59%; P , 0.05) in the control group 
(3.99% ± 1.44%) than in the RA group (39.77% ± 6.35%), the 
percentage with trabecular bone thickness in the range of 0.17–
0.31 mm was significantly lower (13.35% ± 9.29%; P , 0.05) 
in the control group (34.95% ± 9.51%) than in the RA group 
(48.48% ± 2.86%), and the percentage with trabecular bone thick-
ness . 0.31 mm was significantly higher (49.31% ± 10.65%; 
P , 0.05) in the control group (61.06% ± 10.91%) than in the 
RA group (11.75% ± 5.74%, Figure 3).
In terms of periodic changes in the distribution of trabe-
cular bone separation, comparing 4 weeks with 0 weeks, the 
percentage with trabecular bone separation , 0.17 mm increased 
significantly in the control group (increase of 5.75% ± 3.08%; 
P , 0.05). There was no significant change in the percentage 
with trabecular bone separation in the range of 0.17–0.31 mm 
in the control group (increase of 3.22% ± 4.43%; P . 0.05). 
The percentage with trabecular bone separation . 0.31 mm 
decreased signif icantly (decrease of 8.97% ± 6.80%; 
P , 0.05). In the RA group, there was no significant change 
in the distribution of trabecular bone separation (,0.17 mm, 
increase of 2.03% ± 2.74%; 0.17–0.31 mm, decrease of 
2.19% ± 7.16%; .0.31 mm, increase of 0.16% ± 8.74%; 
P . 0.05). Comparing 8 weeks with 4 weeks, the distribution 
of trabecular bone separation showed no significant changes 
in the control group (,0.17 mm, increase of 0.60% ± 3.89%; 
0.17–0.31 mm, decrease of 1.35% ± 6.96%; .0.31 mm, 
increase of 0.75% ± 10.17%; P .  0.05). In the RA group, no 
significant changes in the percentages with trabecular bone 
separation , 0.17 mm (decrease of 10.23% ± 2.75%; P . 0.05) 
or in the range of 0.17–0.31 mm (decrease of 13.41% ± 7.18%; 
P . 0.05) were detected, while the percentage with trabe-
cular bone separation . 0.31 mm increased significantly 
(23.64% ± 8.79%; P , 0.05).
Regarding comparisons of the two groups for each week 
(Figure 4), there was no significant difference between the 
groups at 0 weeks (P . 0.05). However, at 4 weeks, the percent-
age with trabecular bone separation , 0.17 mm was signifi-
cantly higher (6.51% ± 4.46%; P , 0.05) in the control group 
(24.85% ± 4.50%) than in the RA group (18.35% ± 2.49%), the 
percentage with trabecular bone separation that was in the range 
of 0.17–0.31 mm was significantly higher (5.71% ± 3.17%; 
P , 0.05) in the control group (55.53% ± 3.89%) than in the RA 
group (49.82% ± 3.19%), and the percentage with trabecular bone 
separation . 0.31 mm was significantly lower (12.22% ± 6.38%; 
P , 0.05) in the control group (19.60% ± 4.06%) than in the 
RA group (31.82% ± 5.45%). At 8 weeks, the percentage 
with trabecular bone separation , 0.17 mm was significantly 
higher (17.34% ± 4.12%; P , 0.05) in the control group 
(25.45% ± 3.69%) than in the RA group (8.12% ± 1.69%), 
the percentage of trabecular bone separation in the range of 
0.17–0.31 mm in control group (54.18% ± 3.56%) was signifi-
cantly higher (17.77% ± 7.35%; P , 0.05) than in the RA group 
(36.41% ± 7.22%), and the percentage with trabecular bone 
separation . 0.31 mm was significantly lower (35.11% ± 9.38%; 
P , 0.05) in the control group (20.36% ± 5.40%) than in the RA 
group (55.47% ± 8.78%, Figure 4).
Validation of RA induction  
in an animal model
Figure 5 shows external changes in bone shape according 
to changes in the surface of the tibial epiphysis and the 
RA
CON
Anterior view Posterior view
Figure 5 Representative radiologic images of the knee joints of rats in the control 
(upper) and RA (lower) groups at 8 weeks.
Notes: Left, anterior view; right, posterior view, showing bone erosion and 
osteophyte formation.
Abbreviation: RA, rheumatoid arthritis.
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extent of its destruction in the knee joints of rats in the 
control group and the RA group, together with images of 
the reconstructed three-dimensional µ-CT images. The 
reconstructed three-dimensional µ-CT images of knee joints 
from the control group showed no external deformities or 
irregularities. In contrast, the overall bone thickness in the 
RA group was less than that in the control group and the 
shape was unclear. Furthermore, inside the epiphysis, bone 
loss within the trabecular bone was higher than that in the 
control group, and trabecular bone was rarely observed under 
the growth plate of the proximal tibia. There was evidence 
of severe bone erosion in the medial and lateral areas of the 
tibial bone in the three-dimensional µ-CT images, and cal-
lus bone was formed in a dispersed manner. The tibia and 
femoral articular surfaces were observed to be irregular due 
to formation of osteophytes. Figure 6 shows the results of 
histologic examination (hematoxylin and eosin staining) in 
the RA group. Bone erosion, synovitis, and pannus forma-
tion, which are characteristic of RA, were noted in the tibial 
epiphysis. Few osteoclasts were observed within the bone 
matrix of the erosion area in the RA group (original mag-
nification × 10). Although inflammation in the knee joints 
did not appear to be severe, there was evidence of chronic 
inflammation, ie, fibrosis and synovial hypertrophy.
Discussion and conclusion
The CIA rat model is widely used in human RA research. 
Despite its similarity to human RA, the severity of CIA can be 
modulated by changing the amount of CII injected.26 CII doses 
ranging from 75 µg to 1000 µg per rat have been described as 
effective for inducing CIA, and CII doses ranging from 150 µg 
to 300 µg are most commonly used for inducing intermediate 
CIA in rats.26 Symptoms of arthritis first appear 12–16 days 
after immunization with 150–300 µg of CII in outbred rodents, 
such as Sprague-Dawley strains.26 The incidence of RA in 
Sprague-Dawley rats after immunization with 150–300 µg of 
CII is reported to be in the range of 51%–75%.27 Administra-
tion of a booster injection 7 days after primary immunization 
increases the incidence of CIA and helps to ensure a more uni-
form time of onset in groups of rats.26 Based on these observa-
tions, 300 µg of CII with a booster injection was chosen as the 
regimen for the present study. It should be noted that the validity 
of injecting CII as a booster has not been confirmed with respect 
to examining characteristic changes in bone microarchitecture. 
Previous studies of CIA involving injection of 150–300 µg of 
CII and a booster have aimed to assess the level of disease pro-
gression by analyzing cytokine levels, scores for induction of 
joint swelling, formation of anticollagen antibody, and changes 
in bone volume on two-dimensional images, rather than 
investigating (as in the present study) bone microarchitectural 
characteristics in three-dimensional images.25,28–31 Therefore, 
further justification is needed for the choice of CII dose (range 
150–300 µg) that should be used with a booster injection for 
optimal assessment of bone microarchitecture.
The results obtained in the present study indicate that 
bone microarchitecture at the tibial epiphysis in a rat with RA 
adopts a generally resorptive, ie, destructive, pattern over time. 
However, at 4 weeks, despite the overall resorptive pattern 
detected in the RA group, the observed activation of bone 
turnover, as evidenced by increases in BS/BV, trabecular bone 
number, and BV/TV in the RA group did not correspond to the 
resorptive pattern (trabecular bone number and BV/TV may be 
gradually decreased by collagen-induced RA over time owing 
to the resorptive pattern). These results may be explained by 
CON RA 
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Figure 6 Representative histologic image of a knee joint with control, rheumatoid arthritis (RA) and a ×10 magnification of the section of RA (inset), showing evidence of 
bone erosion, inflammation, pannus formation, and synovial hypertrophy (black arrows).





Clinical Interventions in Aging 2012:7
the distribution of trabecular bone thickness and separation. 
The percentage with relatively low trabecular bone thickness 
increased (P , 0.05), while that with relatively high trabecular 
bone thickness decreased (P , 0.05) in the RA group until 
4 weeks (for the trabecular bone thickness distribution, there 
was no significant change in the percentage with trabecular 
bone thickness , 0.17 mm; the percentage with trabecular 
bone thickness in the range of 0.17–0.31 mm increased; and 
the percentage with trabecular bone thickness . 0.31 mm 
decreased), and no significant changes in trabecular bone 
separation distribution were detected (P , 0.05). In other 
words, the increase in relatively low trabecular bone thickness 
and the decrease in relatively low trabecular bone thickness 
may lead to a temporary absence of change in trabecular bone 
separation, resulting in a temporary increase in trabecular 
bone number with no alteration in the BV/TV ratio in the RA 
group up until 4 weeks. At 8 weeks, the resorptive patterns 
corresponded reasonably with the change in bone turnover 
rate as a result of collagen-induced RA over time. These find-
ings suggest that patterns of bone microarchitecture changes 
brought about by RA should be periodically considered in the 
diagnosis and management of rheumatic symptoms over time, 
particularly with respect to prediction of bone fracture risk.
The results obtained in the present study may be affected 
by the ability of the individual animal to adapt which, in turn, 
is dependent on physical/environmental adaption ability and 
stress factors.24,32 Therefore, to confirm our results, it will be 
necessary in a future study to analyze individual adaptation 
capabilities by observing animal behavior and habits. For 
example, by quantifying real-time behavioral patterns using 
a motion-capturing system, in combination with regular clini-
cal and pathologic examination of experimental animals, one 
might improve the accuracy of the results. Nevertheless, the 
present study represents a valuable first approach to tracking 
the periodic and continuous patterns of collagen-induced 
RA-associated microarchitectural changes at the tibial epi-
physis, which should improve our ability to assess fracture 
risk induced by RA at this site over time.
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